Outlook Therapeutics, Inc. [OTLK]

Source: 

Company Overview

Outlook Therapeutics, Inc is a biopharmaceutical company working to launch the first ophthalmic formulation of bevacizumab approved by the U.S. Food and Drug Administration, or the FDA, for use in retinal indications.